Saturday 17 October 2026
Export MBOT’s income statement to Excel — free account
Microbot Medical Inc.
MBOT Healthcare Medical Instruments & Supplies
In the quarter to June 2026, revenue grew 1,047.6%, EPS grew 20.0% and free cash flow fell 98.7%, each against the same quarter a year earlier.
0.95
0.00
0.00%
Follow MBOT
Microbot Medical Inc. (MBOT) P/E ratio
Microbot Medical Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 0.0× (October 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Sep 2015 | 0.0× | — |
| Jun 2015 | 0.0× | — |
| 1 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| STXS Stereotaxis Inc. compare | n/m |
| MBOT Microbot Medical Inc. | n/m |
| POCI Precision Optics Corp. compare | n/m |
| NYXH Nyxoah SA compare | n/m |
| MLSS Milestone Scientific, Inc. compare | n/m |
| HBIO Harvard Bioscience, Inc. compare | n/m |
| ZTEKF Zentek Ltd. compare | n/m |
| DXR Daxor Corporation compare | 4.7× |
| NEPH Nephros Inc. compare | 23.4× |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)